EMD.AX

Emyria Limited EMD.AX

EMD.AX
Emyria Limited IIQ.AX
INOVIQ Ltd AGN.AX
Argenica Therapeutics Limited MAP.AX
Microba Life Sciences Limited NXS.AX
Next Science Limited ENL.AX
Enlitic, Inc. EYE.AX
Nova Eye Medical Limited PTX.AX
Prescient Therapeutics Limited LGP.AX
Little Green Pharma Ltd CTE.AX
Cryosite Limited

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode EMD.AX IIQ.AX AGN.AX MAP.AX NXS.AX ENL.AX EYE.AX PTX.AX LGP.AX CTE.AX
6M 126.67 % -9.09 % -58.09 % -55.68 % 51.52 % -34.00 % 47.62 % -6.67 % 21.74 % 12.82 %
YTD 88.89 % -33.96 % -55.12 % -57.95 % 30.43 % -41.07 % -11.43 % -17.65 % 7.69 % 3.53 %
1Y 112.50 % -30.00 % -62.99 % -48.75 % -25.00 % -49.23 % -18.42 % -4.55 % -9.68 % 0.00 %
3Y -67.26 % -40.17 % -40.00 % -40.08 % -79.73 % -96.12 % -40.38 % -75.29 % -40.43 % 34.35 %
5Y -8.57 % -98.44 % 9.62 % -75.17 % -88.00 % -96.12 % -50.26 % -34.38 % -58.82 % 282.61 %
10Y -51.45 % -59.92 % 9.62 % -75.17 % -88.89 % -96.12 % -68.16 % -26.90 % -60.00 % 193.33 %
From the beginning -51.45 % -99.85 % 9.62 % -75.17 % -88.89 % -96.12 % -98.47 % -99.88 % -60.00 % 133.32 %

Dividend

Nova Eye Medical Limited

Prescient Therapeutics Limited

Cryosite Limited